Table 5

Management of infections at specific sites

Infection siteTreatment
Skin and soft tissues
  • Provide effective wound care (e.g., eradication of necrotic tissue)

  • Perform biopsy of skin lesions for histology and culture

  • Administer empiric antibiotics administered to the wound

  • Refer to the principal treatment of L-CRS for high-risk patients with severe infection caused by L-CRS

Urinary system
  • Monitor routine urine

  • Replace urinary catheters regularly

  • Collect microbiological samples

  • If the patient develops infection-associated symptoms, initiate empiric antibiotic treatment according to local protocols

Intravenous catheter
  • Perform blood cultures for patients suspected of having CRBSI before administration of antimicrobial therapy

  • Remove the catheter from patients with persistent hemodynamic instability or severe sepsis as soon as possible

  • After organism and antibiotic sensitivities have been identified, the antibiotic regimen should be tailored on the basis of culture results

Serosal cavity catheter
  • Perform routine maintenance measures to prevent infection include daily disinfection of the exit site

  • If the patient develops infection-associated symptoms, administer anti-infection treatment

L-CRS, local cytokine-release syndrome; CRBSI, catheter-associated bloodstream infections.